Global Information
회사소개 | 문의 | 비교리스트

BRIC 국가의 당뇨병 치료기기 시장 예측(-2025년) : 종류별(SMBG, CGMS, 란셋, 인슐린 펌프, 인슐린 펜, 인슐린 주사기, 모바일 앱), 치료 환경별(병원·전문 클리닉, 자기 치료·재택 치료), 국가별(브라질, 러시아, 인도, 중국)

Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings(Hospitals & Specialty Clinics, Self & Home Care), & Country (Brazil, Russia, India, China)-Forecast to 2025"

리서치사 MarketsandMarkets
발행일 2020년 06월 상품 코드 942703
페이지 정보 영문 169 Pages
가격
US $ 4,950 ₩ 5,835,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,839,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,607,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,788,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


BRIC 국가의 당뇨병 치료기기 시장 예측(-2025년) : 종류별(SMBG, CGMS, 란셋, 인슐린 펌프, 인슐린 펜, 인슐린 주사기, 모바일 앱), 치료 환경별(병원·전문 클리닉, 자기 치료·재택 치료), 국가별(브라질, 러시아, 인도, 중국) Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings(Hospitals & Specialty Clinics, Self & Home Care), & Country (Brazil, Russia, India, China)-Forecast to 2025"
발행일 : 2020년 06월 페이지 정보 : 영문 169 Pages

BRIC 국가의 당뇨병 치료기기 시장 규모는 2020년 17억 달러에서 2025년까지 43억 달러로, 16.2%의 CAGR로 확대될 것으로 예측됩니다. 시장 성장의 주요 요인으로 당뇨병 환자 급증, 당뇨병 의식 향상 캠페인과 집중적 진단 등에 의한 당뇨병 관리 인식 확산, 유리한 국민 건강 전략, 각국 정부에 의한 의료기기의 적극적 승인 등을 들 수 있습니다.

BRIC 국가(브라질, 러시아, 인도, 중국)의 당뇨병 치료기기(Diabetes Care Devices) 시장에 대해 분석했으며, 시장의 기본 구조와 최신 상황, 주요 시장 성장 촉진·저해요인, 시장 동향 전망(향후 6년간), 종류별·치료 환경별·국가별 상세 동향, 시장 경쟁 상황, 주요 기업 개요 등을 조사했습니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 업계 인사이트

  • 업계 동향
    • 하이브리드 클로즈드 루프 시스템/인공 췌장 기기의 수요 확대
    • 스마트 혈당 미터에 의한 통합형 당뇨병 관리 솔루션의 실현
    • 스마트 인슐린 펜 : 혈당 모니터링 시스템과의 동기에 의한 당뇨병 데이터 공유의 촉진
    • 혁신적인 인슐린 전달 시스템
  • 규제 분석 : 국가별
  • 신종 코로나바이러스 감염증(Covid-19) : BRIC 국가의 당뇨병 치료기기 시장에 대한 영향

제6장 BRIC 국가의 당뇨병 치료기기 시장 : 종류별

  • 서론
  • 혈당 모니터링 시스템
    • 자기 모니터링 시스템
    • 연속 혈당 모니터링 시스템
    • 테스트 스트립
    • 란셋/채혈기구
  • 인슐린 전달 기기
    • 인슐린 펌프
    • 인슐린 펜
    • 인슐린 시린지·니들
  • 당뇨병 관리용 모바일 앱

제7장 당뇨병 치료기기 시장 : 환자 치료 환경별

  • 서론
  • 자기 치료·재택 치료
  • 병원, 당뇨병 전문 클리닉

제8장 BRIC 국가의 당뇨병 치료기기 시장

  • 서론
  • 중국 시장
    • 서론
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 시장 기회
    • 시장 과제
  • 인도 시장
  • 브라질 시장
  • 러시아 시장

제9장 경쟁 상황

  • 개요
  • 제품 비교 분석
  • 주요 기업의 활동 지역(2019년)
  • 연구개발(R&D) 비용 : BRIC 국가의 주요 기업
  • 시장 점유율 분석
    • 브라질 : 당뇨병 치료기기 시장 점유율 분석
    • 러시아 : 당뇨병 치료기기 시장 점유율 분석
    • 인도 : 당뇨병 치료기기 시장 점유율 분석
    • 중국 : 당뇨병 치료기기 시장 점유율 분석
  • 경쟁 상황과 동향
    • 사업 제휴·협력, 계약
    • 제품 승인, 출시, 갱신

제10장 기업 개요(사업 개요, 주요 제품, 최근의 동향, SWOT 분석, MnM의 견해)

  • F. HOFFMAN-LA ROCHE LTD.
  • ABBOTT
  • ASCENSIA DIABETES CARE HOLDINGS AG
  • DEXCOM, INC.
  • MEDTRONIC PLC
  • B. BRAUN MELSUNGEN AG
  • BECTON, DICKINSON AND COMPANY
  • ACON LABORATORIES, INC.
  • ARKRAY, INC.
  • SANOFI
  • NOVO NORDISK A/S
  • TERUMO CORPORATION
  • YPSOMED
  • SINOCARE, INC.
  • AGAMATRIX HOLDINGS LLC
  • LIFESCAN
  • SD BIOSENSOR, INC.
  • MICROGENE DIAGNOSTIC SYSTEMS PVT. LTD.
  • DR. MOREPEN
  • BIONIME CORPORATION
  • ROSSMAX INTERNATIONAL LTD.

제11장 부록

KSM 20.07.03

LIST OF TABLES

  • TABLE 1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE DIABETES CARE DEVICES MARKET
  • TABLE 2 EXCHANGE RATES UTILIZED FOR USD CONVERSION
  • TABLE 3 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO
  • TABLE 4 MAJOR SMART GLUCOSE METERS AVAILABLE GLOBALLY
  • TABLE 5 MAJOR SMART INSULIN PENS AVAILABLE GLOBALLY
  • TABLE 6 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES IN BRIC COUNTRIES
  • TABLE 7 CHINA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 8 INDIA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 9 BRAZIL: MEDICAL DEVICE CLASSIFICATION
  • TABLE 10 RUSSIA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 11 AVERAGE SELLING PRICE ANALYSIS OF DIABETES CARE DEVICES (BRIC MARKET)
  • TABLE 12 DIABETES CARE DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 13 DIABETES CARE DEVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 14 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 15 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 16 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 17 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2020-2025 (THOUSAND UNITS)
  • TABLE 18 MAJOR SELF-MONITORING BLOOD GLUCOSE METERS AVAILABLE IN BRIC COUNTRIES
  • TABLE 19 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 20 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2020-2025 (THOUSAND UNITS)
  • TABLE 21 MAJOR CONTINUOUS GLUCOSE MONITORING SYSTEMS AVAILABLE IN BRIC COUNTRIES
  • TABLE 22 TEST STRIPS/TEST PAPERS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 23 TEST STRIPS/TEST PAPERS (100 STRIPS) MARKET, BY COUNTRY, 2020-2025 (THOUSAND UNITS)
  • TABLE 24 MAJOR TEST STRIPS/TEST PAPERS AVAILABLE IN BRIC COUNTRIES
  • TABLE 25 LANCETS/LANCING DEVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 26 LANCETS (PER 100) & LANCING DEVICES (PER UNIT) MARKET, BY COUNTRY, 2020-2025 (THOUSAND UNITS)
  • TABLE 27 MAJOR LANCETS/LANCING DEVICES AVAILABLE IN BRIC COUNTRIES
  • TABLE 28 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 29 INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 30 INSULIN PUMPS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 31 INSULIN PUMPS MARKET, BY COUNTRY, 2020-2025 (THOUSAND UNITS)
  • TABLE 32 MAJOR INSULIN PUMPS AVAILABLE IN BRIC COUNTRIES
  • TABLE 33 INSULIN PENS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 34 INSULIN PENS MARKET, BY COUNTRY, 2020-2025 (THOUSAND UNITS)
  • TABLE 35 MAJOR INSULIN PENS AVAILABLE IN BRIC COUNTRIES
  • TABLE 36 INSULIN SYRINGES AND NEEDLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 37 INSULIN SYRINGES AND NEEDLES (PER 100) MARKET, BY COUNTRY, 2020-2025 (THOUSAND UNITS)
  • TABLE 38 INSULIN SYRINGES AND NEEDLES AVAILABLE IN BRIC COUNTRIES
  • TABLE 39 DIABETES MANAGEMENT MOBILE APPLICATIONS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 40 MAJOR DIABETES MANAGEMENT APPLICATIONS AVAILABLE IN BRIC COUNTRIES
  • TABLE 41 DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2018-2025 (USD MILLION)
  • TABLE 42 DIABETES CARE DEVICES MARKET FOR SELF/HOME HEALTHCARE, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 43 DIABETES CARE DEVICES MARKET FOR HOSPITAL & DIABETES SPECIALTY CLINICS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 44 CHINA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 45 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 46 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 47 CHINA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2018-2025 (USD MILLION)
  • TABLE 48 INDIA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 49 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 50 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 51 INDIA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2018-2025 (USD MILLION)
  • TABLE 52 BRAZIL: DIABETES CARE DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 53 BRAZIL: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 54 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 55 BRAZIL: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2018-2025 (USD MILLION)
  • TABLE 56 RUSSIA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 57 RUSSIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 58 RUSSIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 59 RUSSIA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2018-2025 (USD MILLION)
  • TABLE 60 MARKET EVALUATION MATRIX (2018-2020)
  • TABLE 61 BRAZIL: DIABETES CARE DEVICES MARKET RANKING, BY KEY PLAYER, 2019
  • TABLE 62 RUSSIA: DIABETES CARE DEVICES MARKET RANKING, BY KEY PLAYER, 2019
  • TABLE 63 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2019-2020)
  • TABLE 64 PRODUCT APPROVALS, LAUNCHES, AND UPGRADES (2019)

LIST OF FIGURES

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRY
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 DIABETES CARE DEVICES (BRIC) MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  • FIGURE 9 SELF/HOME HEALTHCARE WILL DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE DIABETES CARE DEVICES (BRIC) MARKET
  • FIGURE 11 INCREASING PREVALENCE OF DIABETES AND THE GROWING DEMAND FOR NON-INVASIVE GLUCOSE MONITORING AND DIGITAL DIABETES SOLUTIONS DRIVE THE GROWTH OF THE MARKET
  • FIGURE 12 INDIA TO REGISTER THE FASTEST GROWTH IN THE DIABETES CARE DEVICES (BRIC) MARKET DURING THE FORECAST PERIOD
  • FIGURE 13 BRAZIL TO WITNESS THE SECOND-FASTEST GROWTH DURING THE FORECAST PERIOD (2020-2025)
  • FIGURE 14 GEOGRAPHIC SNAPSHOT: DIABETES CARE DEVICES MARKET IN BRIC COUNTRIES
  • FIGURE 15 NUMBER OF ADULT DIABETICS IN CHINA (MILLION)
  • FIGURE 16 CHINA: DIABETES CARE DEVICES MARKET SNAPSHOT
  • FIGURE 17 TOP 5 COUNTRIES WITH THE HIGHEST NUMBER OF CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (0-14 YEARS) IN 2019
  • FIGURE 18 INDIA: DIABETES CARE DEVICES MARKET SNAPSHOT
  • FIGURE 19 YEAR-ON-YEAR DIABETES PREVALENCE (BRAZIL)
  • FIGURE 20 BRAZIL: DIABETES CARE DEVICE MARKET SNAPSHOT
  • FIGURE 21 POPULATION AGED ABOVE 65 YEARS AS A PERCENTAGE OF TOTAL POPULATION (RUSSIA)
  • FIGURE 22 RUSSIA: DIABETES CARE DEVICES MARKET SNAPSHOT
  • FIGURE 23 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2018 AND MAY 2020
  • FIGURE 24 PRODUCT PORTFOLIO ANALYSIS: DIABETES CARE DEVICES MARKET
  • FIGURE 25 DOMESTIC AND FOREIGN PLAYERS IN THE BRAZILIAN DIABETES CARE DEVICES MARKET
  • FIGURE 26 DOMESTIC AND FOREIGN PLAYERS IN THE RUSSIAN DIABETES CARE DEVICES MARKET
  • FIGURE 27 DOMESTIC AND FOREIGN PLAYERS IN THE INDIAN DIABETES CARE DEVICES MARKET
  • FIGURE 28 INDIA: DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2019
  • FIGURE 29 DOMESTIC & FOREIGN PLAYERS IN THE CHINESE DIABETES CARE DEVICES MARKET
  • FIGURE 30 CHINA: DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2019
  • FIGURE 31 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MAJOR PLAYERS BETWEEN 2018 AND 2020
  • FIGURE 32 F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT (2019)
  • FIGURE 33 ABBOTT: COMPANY SNAPSHOT (2019)
  • FIGURE 34 DEXCOM, INC.: COMPANY SNAPSHOT (2019)
  • FIGURE 35 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
  • FIGURE 36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
  • FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
  • FIGURE 38 SANOFI: COMPANY SNAPSHOT (2019)
  • FIGURE 39 NOVO NORDISK A/S: COMPANY SNAPSHOT (2019)
  • FIGURE 40 TERUMO CORPORATION: COMPANY SNAPSHOT (2019)
  • FIGURE 41 YPSOMED: COMPANY SNAPSHOT (2019)
  • FIGURE 42 SINOCARE, INC.: COMPANY SNAPSHOT (2019)

"The diabetes care devices (BRIC) market is projected to grow at a CAGR of 16.2%"

The diabetes care devices (BRIC) market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period. The growth in this market is primarily attributed to the sharp increase in diabetes, increasing awareness of diabetes management due to the rising number of diabetes awareness campaigns and screening camps, favorable national health strategies, and government-led endorsement of medical devices.

"By type, under the insulin delivery devices segment, insulin pens to hold the largest share during the forecast period"

Within the type category, the diabetes care devices (BRIC) market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. Within the insulin delivery devices segment, insulin pens held the largest share in the market. The increasing affordability of insulin pens, convenience, ease-of-use, and technological advancements in these devices that promote integrated diabetes management support the growth of this segment.

"By end user, the self/ home healthcare segment is expected to grow at a higher rate during the forecast period (2020-2025)"

Based on end user, the diabetes care devices (BRIC) market has been segmented into hospital & specialty clinics and self/home healthcare. The self/home healthcare segment is expected to grow at a higher CAGR due to the increasing awareness of self-management of diabetes, increasing portability of diabetes care devices, and technological innovations that provide real-time insights for patients and healthcare providers for decision-making regarding diabetes control and treatment planning.

"India is projected to grow at the highest CAGR"

China is expected to account for the largest share of the diabetes care devices (BRIC) market in 2019. The large share of this region can primarily be attributed to the sharp increase in the diabetic population in the past decade and endorsements of medical devices by the government. On the other hand, India is expected to witness the highest CAGR during the forecast period due to the increasing government investment in the medical devices industry, high prevalence of type 1 and gestational diabetes cases, and increasing diabetes awareness creation through campaigns and screening camps.

Breakdown of Primary Participants:

  • By Company Type: Tier 1: 30%, Tier 2: 45%, and Tier 3: 25%
  • By Designation: C-level: 35%, Director Level: 25%, and Others: 40%
  • By Country: Brazil: 30%, India: 30%, China: 15%, Russia: 25%

Research Coverage:

The report analyzes the various diabetes care devices in the BRIC market and their adoption patterns among end users such as self/home healthcare and hospitals & specialty clinics. It aims at estimating the market size and future growth potential of the diabetes care devices (BRIC) market for different segments, such as type, end user, and country. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:

The report will help established firms, as well as new entrants/smaller firms, gauge the pulse of the market, which, in turn, would help them garner a larger share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following:

  • Market Penetration: Comprehensive information on the service portfolios offered by the top players in the diabetes care devices (BRIC) market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the diabetes care devices (BRIC) market
  • Market Development: Comprehensive information on the lucrative emerging countries, by type and end user
  • Market Diversification: Exhaustive information about new products and recent developments in the diabetes care devices (BRIC) market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and services offered by leading players in the diabetes care devices (BRIC) market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primary sources
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 DIABETES CARE DEVICES MARKET OVERVIEW
  • 4.2 DIABETES CARE DEVICES (BRIC) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.3 DIABETES CARE DEVICES (BRIC) MARKET: COUNTRY MIX (2020-2025)

5 INDUSTRY INSIGHTS

  • 5.1 INDUSTRY TRENDS
    • 5.1.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
    • 5.1.2 SMART GLUCOSE METERS ENABLE INTEGRATED DIABETES MANAGEMENT SOLUTIONS
    • 5.1.3 SMART INSULIN PEN SYNCHRONIZATION WITH GLUCOSE MONITORING SYSTEMS PROMOTES DIABETES DATA SHARING
    • 5.1.4 INNOVATIVE INSULIN DELIVERY SYSTEMS
  • 5.2 REGULATORY ANALYSIS
    • 5.2.1 CHINA
    • 5.2.2 INDIA
    • 5.2.3 BRAZIL
    • 5.2.4 RUSSIA
  • 5.3 COVID-19 IMPACT ON THE DIABETES CARE DEVICES (BRIC) MARKET

6 DIABETES CARE DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 BLOOD GLUCOSE MONITORING SYSTEMS
    • 6.2.1 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS
      • 6.2.1.1 Technological innovations to drive the growth of self-monitoring blood glucose monitoring systems
    • 6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS
      • 6.2.2.1 Increasing collaborations, partnerships, and agreements between companies to develop integrated CGM systems to drive the growth of this market
    • 6.2.3 TEST STRIPS/TEST PAPERS
      • 6.2.3.1 Shift toward non-invasive methods for blood glucose monitoring to restrain the growth of this market during the forecast period
    • 6.2.4 LANCETS/LANCING DEVICES
      • 6.2.4.1 Rising focus to reduce the chances of infection and accidental pricking to increase the popularity of safety lancets during the forecast period
  • 6.3 INSULIN DELIVERY DEVICES
    • 6.3.1 INSULIN PUMPS
      • 6.3.1.1 Insulin pumps integrated with continuous glucose monitoring systems offer the benefits of data integration and diabetes management
    • 6.3.2 INSULIN PENS
      • 6.3.2.1 The convenience of use of insulin pens and increasing affordability could drive the growth of this segment during the forecast period
    • 6.3.3 INSULIN SYRINGES AND NEEDLES
      • 6.3.3.1 Safety concerns and increasing awareness of affordable alternatives in the market could restrain the growth of this segment during the forecast period
  • 6.4 DIABETES MANAGEMENT MOBILE APPLICATIONS
    • 6.4.1 GROWING ADOPTION OF BLOOD GLUCOSE TRACKING APPS AND INCREASING AWARENESS OF DIABETES AMONG PATIENTS TO DRIVE MARKET GROWTH

7 DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS

  • 7.1 INTRODUCTION
  • 7.2 SELF/HOME HEALTHCARE
    • 7.2.1 INCREASING AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES HAS FUELED THE PREFERENCE FOR SELF/HOME HEALTHCARE
  • 7.3 HOSPITALS & DIABETES SPECIALTY CLINICS
    • 7.3.1 RISING DEMAND FOR POC TESTING IN HOSPITALS BOOSTS THE MARKET GROWTH

8 DIABETES CARE DEVICES MARKET IN BRIC COUNTRIES

  • 8.1 INTRODUCTION
  • 8.2 CHINA: DIABETES CARE DEVICES MARKET
    • 8.2.1 INTRODUCTION
    • 8.2.2 MARKET DRIVERS
      • 8.2.2.1 Sharp increase in diabetes in the past decade
      • 8.2.2.2 Favorable national health strategies
      • 8.2.2.3 Government-LED endorsement of the medical device industry
    • 8.2.3 MARKET RESTRAINTS
      • 8.2.3.1 Traditional Chinese medicine as an alternative
      • 8.2.3.2 High cost of advanced diabetes management devices
    • 8.2.4 MARKET OPPORTUNITIES
      • 8.2.4.1 Significant advancements and leveraging of artificial intelligence and big data
    • 8.2.5 MARKET CHALLENGES
      • 8.2.5.1 Lack of adherence of patients to recommended diabetes treatment guidelines
  • 8.3 INDIA: DIABETES CARE DEVICES MARKET
    • 8.3.1 INTRODUCTION
    • 8.3.2 MARKET DRIVERS
      • 8.3.2.1 High prevalence of diabetes
      • 8.3.2.2 Government's "Make in India" campaign to encourage local manufacturing of medical devices
      • 8.3.2.3 Diabetes awareness campaigns and screening camps
    • 8.3.3 MARKET RESTRAINTS
      • 8.3.3.1 Lack of accessibility to healthcare
      • 8.3.3.2 Inadequate health insurance coverage
    • 8.3.4 MARKET OPPORTUNITIES
      • 8.3.4.1 Rising adoption of Mhealth
    • 8.3.5 MARKET CHALLENGES
      • 8.3.5.1 Shortage of healthcare professionals in diabetes management
  • 8.4 BRAZIL: DIABETES CARE DEVICES MARKET
    • 8.4.1 INTRODUCTION
    • 8.4.2 MARKET DRIVERS
      • 8.4.2.1 High prevalence of diabetes
      • 8.4.2.2 Favorable government policies
    • 8.4.3 MARKET RESTRAINTS
      • 8.4.3.1 Lack of awareness of diabetes care
      • 8.4.3.2 High prices of advanced diabetes care devices
    • 8.4.4 MARKET OPPORTUNITIES
      • 8.4.4.1 Increasing penetration of smartphones and rising focus on digital health to drive the growth of diabetes management platforms and diabetes management mobile applications
    • 8.4.5 MARKET CHALLENGES
      • 8.4.5.1 Strict regulatory guidelines and regulatory process for medical devices
  • 8.5 RUSSIA: DIABETES CARE DEVICES MARKET
    • 8.5.1 INTRODUCTION
    • 8.5.2 MARKET DRIVERS
      • 8.5.2.1 Rising elderly population
      • 8.5.2.2 Increasing rate of obesity
    • 8.5.3 MARKET RESTRAINTS
      • 8.5.3.1 Large number of undiagnosed diabetics
    • 8.5.4 MARKET OPPORTUNITIES
      • 8.5.4.1 Government spending on healthcare
      • 8.5.4.2 Rising investment of pharma market players to establish local manufacturing plants
    • 8.5.5 MARKET CHALLENGES
      • 8.5.5.1 Low adoption of glucose monitoring systems

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 PRODUCT BENCHMARKING
  • 9.3 GEOGRAPHIC REACH OF THE TOP MARKET PLAYERS (2019)
  • 9.4 R&D EXPENDITURE: KEY PLAYERS IN THE DIABETES CARE DEVICES (BRIC) MARKET
  • 9.5 MARKET SHARE ANALYSIS
    • 9.5.1 BRAZIL: DIABETES CARE DEVICES MARKET SHARE ANALYSIS
    • 9.5.2 RUSSIA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS
    • 9.5.3 INDIA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS
    • 9.5.4 CHINA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS
  • 9.6 COMPETITIVE SITUATION AND TRENDS
    • 9.6.1 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
    • 9.6.2 PRODUCT APPROVALS, LAUNCHES, AND UPGRADES

10 COMPANY PROFILES (Business overview, Products offered, Recent developments, SWOT analysis, MNM view)*

  • 10.1 F. HOFFMAN-LA ROCHE LTD.
  • 10.2 ABBOTT
  • 10.3 ASCENSIA DIABETES CARE HOLDINGS AG
  • 10.4 DEXCOM, INC.
  • 10.5 MEDTRONIC PLC
  • 10.6 B. BRAUN MELSUNGEN AG
  • 10.7 BECTON, DICKINSON AND COMPANY
  • 10.8 ACON LABORATORIES, INC.
  • 10.9 ARKRAY, INC.
  • 10.10 SANOFI
  • 10.11 NOVO NORDISK A/S
  • 10.12 TERUMO CORPORATION
  • 10.13 YPSOMED
  • 10.14 SINOCARE, INC.
  • 10.15 AGAMATRIX HOLDINGS LLC
  • 10.16 LIFESCAN
  • 10.17 SD BIOSENSOR, INC.
  • 10.18 MICROGENE DIAGNOSTIC SYSTEMS PVT. LTD.
  • 10.19 DR. MOREPEN
  • 10.20 BIONIME CORPORATION
  • 10.21 ROSSMAX INTERNATIONAL LTD.

Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 INSIGHTS OF INDUSTRY EXPERTS
  • 11.2 DISCUSSION GUIDE
  • 11.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.4 AVAILABLE CUSTOMIZATIONS
  • 11.5 RELATED REPORTS
  • 11.6 AUTHOR DETAILS
Back to Top
전화 문의
F A Q